ALLMedicine™ Allergic Bronchopulmonary Aspergillosis Center
Research & Reviews 191 results
Expert Review of Anti-infective Therapy; Echeverria-Esnal D, Martín-Ontiyuelo C et. al.
Jul 31st, 2021 - Aspergillus may cause different types of lung infections: invasive, chronic pulmonary or allergic bronchopulmonary aspergillosis. Pharmacological management with antifungals poses as a challenge. Patients diagnosed with pulmonary aspergillosis are...
Allergy Lukaszewicz R, Mahay G et. al.
Jul 13th, 2021 - Medical algorithm: Aspergillus fumigatus components in the diagnosis of Allergic Bronchopulmonary Aspergillosis.|2021|Lukaszewicz R,Mahay G,Boyer O,Martinet J,|
PloS One; Keizer EM, Valdes ID et. al.
Jul 10th, 2021 - Conidia of Aspergillus fumigatus are inhaled by humans on daily basis. As a consequence, these conidia can cause infections that differ in severity ranging from allergic bronchopulmonary aspergillosis to invasive aspergillosis. In this study we co...
PloS One; Kwizera R, Bongomin F et. al.
May 29th, 2021 - Diagnosis of fungal allergies in asthma remains problematic in low-and middle-income countries due to non-availability of point-of-care testing. In this study, we aimed to evaluate the performance of an Aspergillus immunochromatographic technology...
The Journal of Asthma : Official Journal of the Associati... Wang S, Zhang J et. al.
Mar 19th, 2021 - Allergic bronchopulmonary aspergillosis (ABPA) is classified radiologically as serologic ABPA (ABPA-S) or ABPA with central bronchiectasis (ABPA-CB). This retrospective case series study aimed to describe and compare the clinical characteristics o...
Drugs 8 results see all →
Clinicaltrials.gov 8 results
Aug 23rd, 2018 - The management of allergic bronchopulmonary aspergillosis (ABPA) includes two important aspects namely institution of immunosuppressive therapy in the form of glucocorticoids to control the immunologic activity, and close monitoring for detection ...
Aug 23rd, 2018 - Allergic bronchopulmonary aspergillosis (ABPA) is a immunological pulmonary disorder caused by hypersensitive reaction to spores of Aspergillus fumigatus. The prevalence of disease is about 1-2% in asthmatics and 2-15% in patients with cystic fibr...
Mar 29th, 2018 - Many patients with cystic fibrosis (CF) cough up mucus or have throat cultures that grow a common fungus called Aspergillus. In patients with CF, aspergillus is not known to cause direct damage to the lungs, but some patients respond with an aller...
Jan 26th, 2018 - Compare the incidence of severe clinical exacerbations in the treatment of ABPA, between a strategy with a maintenance treatment and a conventional strategy without antifungal maintenance therapy.
Aug 30th, 2017 - Allergic bronchopulmonary Aspergillosis (ABPA) is a pulmonary hypersensitivity disease mediated by an allergic response to Aspergillus fumigates. ABPA occurs in, 10% of cystic fibrosis (CF) patients and may lead to acute worsening of respiratory s...
News 1 results
Jun 4th, 2019 - Blood eosinophilia > 4% or 300-400 cells/μL supports the diagnosis of asthma, but the absence of this finding is not exclusionary. Total serum immunoglobulin E levels > 100 IU/mL are frequently observed in patients experiencing allergic reactions,...